← Browse by Condition
Medical Condition

diabete type 2

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for diabete type 2 sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — diabete type 2 Clinical Trials

How many clinical trials are currently recruiting for diabete type 2?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for diabete type 2, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for diabete type 2?
diabete type 2 research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a diabete type 2 clinical trial?
Eligibility criteria for diabete type 2 trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
GCS Ramsay Santé pour l'Enseignement et la Recherche 1 trial
University of Athens 1 trial
University Hospital, Geneva 1 trial
Sichuan Academy of Medical Sciences 1 trial
Ankara Medipol University 1 trial

Recruiting Clinical Trials

NCT05325710
Recruiting
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Enrollment
230 pts
Location
France
Sponsor
GCS Ramsay Santé pour l'Enseig...
View Trial →
NCT07469943
Recruiting
The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness and Cardiac Deformation After Acute Myocardial Infarction
Enrollment
80 pts
Location
Greece
Sponsor
University of Athens
View Trial →
NCT07506356
Recruiting
Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
Enrollment
38 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
View Trial →
NCT07676773
Recruiting
Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
Enrollment
80 pts
Location
China
Sponsor
Sichuan Academy of Medical Sci...
View Trial →
NCT07847294
Recruiting
The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes
Enrollment
42 pts
Location
Turkey (Türkiye)
Sponsor
Ankara Medipol University
View Trial →

Related Conditions

myocardial infarction mi (1) regurgitation (1) pulmonary aspiration during anaesthetic induction (1) cardio respiratory fitness (1) diabetes in adults (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology